Search

Your search keyword '"David A. Sweetser"' showing total 121 results

Search Constraints

Start Over You searched for: Author "David A. Sweetser" Remove constraint Author: "David A. Sweetser"
121 results on '"David A. Sweetser"'

Search Results

1. Tle4 controls both developmental acquisition and early post-natal maturation of corticothalamic projection neuron identity

3. A pooled electronic consultation program to improve access to genetics specialists

4. A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

5. TLE4 Is a Critical Mediator of Osteoblast and Runx2-Dependent Bone Development

6. Missense variants in CTNNB1 can be associated with vitreoretinopathy—Seven new cases of CTNNB1‐associated neurodevelopmental disorder including a previously unreported retinal phenotype

7. The recurrent de novo c.2011C>T missense variant in MTSS2 causes syndromic intellectual disability

8. De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues

9. Heterozygous variants in PRPF8 are associated with neurodevelopmental disorders

10. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

11. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

12. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

13. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

14. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

15. One is the loneliest number: genotypic matchmaking using the electronic health record

16. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

17. A homozygous splice variant in ATP5PO, disrupts mitochondrial complex V function and causes Leigh syndrome in two unrelated families

18. Gain-of-function mutations in

19. A retrospective study of adult patients with noncirrhotic hyperammonemia

20. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder

21. De Novo Variants in the ATPase Module of MORC2 Cause a Neurodevelopmental Disorder with Growth Retardation and Variable Craniofacial Dysmorphism

22. Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7

23. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

24. A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

25. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

26. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

27. De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms

28. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

29. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

30. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

31. Clinical, neuroimaging, and molecular spectrum of TECPR2 ‐associated hereditary sensory and autonomic neuropathy with intellectual disability

32. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

33. Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity

34. Heterozygous variants in PRPF8 are associated with neurodevelopmental disorders

35. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

36. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

37. Expanding the phenotypic spectrum of GABRG2 variants: a recurrent GABRG2 missense variant associated with a severe phenotype

38. The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

39. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay

40. WNT/β-Catenin Pathway and Epigenetic Mechanisms Regulate the Pitt-Hopkins Syndrome and Schizophrenia Risk Gene TCF4

41. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3

42. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

43. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

44. A specialized post‐transcriptional program in chemoresistant, quiescent cancer cells

45. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing

46. A genome-wide DNA methylation signature for SETD1B-related syndrome

47. Diagnosis and management in Pitt-Hopkins syndrome: First international consensus statement

48. A description of novel variants and review of phenotypic spectrum in UBA5-related early epileptic encephalopathy

49. Case 34-2016

50. Abstract B32: A specialized post-transcriptional program in chemoresistant, quiescent cancer cells

Catalog

Books, media, physical & digital resources